Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Daunorubicin
Active Ingredient: Daunorubicin hydrochloride 2.14mg/mL equivalent to daunorubicin 2mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer (Perth) Pty Limited, Bentley, Australia
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 17th day of June 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).